14 March 2017
Virginia
Reporter: Barney Dixon

PTAB upholds Acorda patents


Hedge fund manager Kyle Bass has lost a US Patent Trial and Appeal Board (PTAB) inter-partes review that sought to invalidate four patents belonging to Acorda Therapeutics.

The patents relate to Acorda’s Ampyra drug, which is aimed at improving walking for adults with multiple sclerosis.

Bass filed the claim through his Coalition for Affordable Drugs, and argued that all four patents should be held invalid as unpatentable.

But in its 9 March decision, the PTAB said that it was “not persuaded” by Bass’s arguments and he had not “demonstrated by a preponderance of evidence the challenged claims are unpatentable on the instituted grounds”.

Ron Cohen, president and CEO of Acorda, said: “The court decision reflects the merits of the case we presented and the validity and strength of our intellectual property for Ampyra.”

“Medical innovation depends on the recognition of valid intellectual property claims.”

He added: “[We] will continue to defend the validity of our intellectual property rights for Ampyra.”

These four patents, as well as another relating to Ampyra, have also been challenged in the US District Court for the District of Delaware, but the court has yet to issue its decision.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Patent perception must shift, says Schecter
13 December 2017 | London | Reporter: Barney Dixon
Public perception must shift if the US is to find feasible solutions to patent abuse, according to chief patent counsel at IBM Manny Schecter
Patent owners winning in IPR
12 December 2017 | New York | Reporter: Barney Dixon
Patent owners are winning more than losing in IPR proceedings, according to a study from law firm Fitzpatrick, Cella, Harper & Scinto
High tech companies weigh in on Allergan deal
11 December 2017 | Washington DC | Reporter: Barney Dixon
Tech companies have argued that Allergan should not be allowed to circumvent the inter partes review process with its controversial patent deal with the Saint Regis Mohawk Tribe
BlackBerry to pay $137 million to Nokia
08 December 2017 | Waterloo | Reporter: Barney Dixon
BlackBerry will pay $137 million to Nokia after the International Chamber of Commerce’s International Court of Arbitration ruled against the company in a patent licensing dispute
ILO ruling “vote of no confidence” for Battistelli, says CSC
07 December 2017 | Munich | Reporter: Barney Dixon
In an open letter to the EPO’s heads of delegations, the CSC said that it interpreted the ILO’s decision as a “massive vote of no confidence in the president of the EPO"
China world’s top patent filer in 2016
07 December 2017 | Geneva | Reporter: Barney Dixon
China has emerged as the top patent filer in the world, accounting for nearly all of the 8 percent growth in patent applications in 2016
EPO president’s impartiality questioned at ILO
06 December 2017 | Geneva | Reporter: Barney Dixon
The International Labour Organisation has questioned the impartiality of EPO president Benoît Battistelli, in two tribunal decisions concerning an EPO employee, and found that there was a conflict of interest on the part of the president